Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    CYC682 – 12
Show Display Options
Rank Status Study
1 Recruiting A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Sapacitabine and decitabine;   Drug: Decitabine

Indicates status has not been verified in more than two years